MORI Ichiro




Project Professor

Research Field

Medicinal Chemistry, Organic Chemistry, Computational Chemistry


Educational Background

Master of Science (MS), Organic Chemistry, Kyoto University, 1984
Ph.D., Chemistry, University of California, Berkeley, 1989

Current Position

Professor, Graduate School of Science, Technology and Innovation 
Department of Science, Technology and Innovation, Kobe University
Concurrent post: CREATE, Kobe University

Research Career

2016-present Project Professor, Graduate School of Science, Technology and Innovation, Kobe University
2012-2016 Project Professor, CREATE, Kobe University. Development of programs for Continuing Professional Development (CPD) for Ph.D. students, postdocs, and young researchers in the area of life science.
2010-2012 Scientific Advisor, Sapala Organics Pvt. Ltd.
2008-2010 Director Business Development, RaQualia Pharma Inc.
2003-2008 Chemistry Department Head, Pfizer
1998-2002 Chemistry Department Head, GlaxoSmithKline
1989-1998 Group Leader in Chemistry, Novartis (formerly Ciba-Geigy)


Obtained Ph. D. from University of California, Berkeley in the area of synthetic organic chemistry. and as a medicinal chemist, I worked with several global pharmaceutical companies, Novartis, GSK, Pfizer for nearly 20years. I have also an experience in business development (liscensing) with RaQualia, which is a spin-off from Pfizer, and SapalaOrganics, CRO in India, for synthetic support in Japan.
In 2012, I joined Kobe University and I starged working with people in academia and industry in the area of life science to help researchers continue professional development (CPD) by widening thire knowledge in life science busines and supporing their human networks.
Since 2016, I obtaiend current position to teach graduage students "Advance Medical Science" , especially Drug Discovery process and have restared reserch as a medicinal and computational chemist. I am currently supporting several drug discovery projects at Kobe University, utilizing my experience and human networks in pharmaceutical industry.